AlphaGrep UK’s Qiagen QGEN Stock Holding History

AlphaGrep UK’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,641	Closed	-$226K	–	913
2026 Q1	$226K	Buy	+5,641	New	+$267K	0.07%	663

Other funds holding QGEN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AlphaGrep UK's QGEN Position: Q2 2026 in Review

AlphaGrep UK sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 5,641 shares — an estimated $226K sold.

AlphaGrep UK first reported a position in QGEN in Q1 2026 and held it in 1 quarter. The position peaked at $226K in Q1 2026. 311 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

AlphaGrep UK reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 5,641 Qiagen shares in Q2 2026, an estimated $226K.
AlphaGrep UK first reported a position in Qiagen in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Qiagen position peaked at $226K in Q1 2026.
311 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.